Oregon Health and Science University, Portland;
Memorial Sloan-Kettering Cancer Center, New York, NY;
Centro de Tratamento e Pesquisa Hospital do Câncer A. C. Camargo, São Paulo, Brazil;
The Cleveland Clinic Foundation, Cleveland, Ohio
Objective: To create and externally validate a nomogram for predicting, for individual patients, locoregional recurrence-free survival (LRFS) after primary surgical treatment of oral cavity squamous cell carcinoma (OCSCC).